悦康药业一季度亏损4927万元同比降171.1%

财中社2025-04-28

4月28日，悦康药业(688658)公布2025年一季报，公司营业收入为5.77亿元，同比下降40.3%；归母净利润亏损4927万元，同比下降171.1%；扣非归母净利润亏损5347万元，同比下降182.7%；经营现金流净额为8104万元，同比下降44.5%；EPS(全面摊薄)为-0.1095元。截至一季度末，公司总资产56.11亿元，较上年度末下降2.2%；归母净资产为35.28亿元，较上年度末...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530605405?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-28 19:22","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2530605405","market":"sh","top_or_hot":-1,"title":"悦康药业一季度亏损4927万元 同比降171.1%","media":"财中社","content":"<div>\n<p>4月28日，悦康药业(688658)公布2025年一季报，公司营业收入为5.77亿元，同比下降40.3%；归母净利润亏损4927万元，同比下降171.1%；扣非归母净利润亏损5347万元，同比下降182.7%；经营现金流净额为8104万元，同比下降44.5%；EPS(全面摊薄)为-0.1095元。截至一季度末，公司总资产56.11亿元，较上年度末下降2.2%；归母净资产为35.28亿元，较上年度末...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042819231194e5ca5e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>悦康药业一季度亏损4927万元 同比降171.1%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n悦康药业一季度亏损4927万元 同比降171.1%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-28 19:22 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042819231194e5ca5e&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>4月28日，悦康药业(688658)公布2025年一季报，公司营业收入为5.77亿元，同比下降40.3%；归母净利润亏损4927万元，同比下降171.1%；扣非归母净利润亏损5347万元，同比下降182.7%；经营现金流净额为8104万元，同比下降44.5%；EPS(全面摊薄)为-0.1095元。截至一季度末，公司总资产56.11亿元，较上年度末下降2.2%；归母净资产为35.28亿元，较上年度末...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042819231194e5ca5e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688658","symbol_name":"悦康药业","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042819231194e5ca5e&s=b","article_id":"2530605405","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042819231194e5ca5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2530605405","pubTimestamp":1745839334,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"4月28日，悦康药业公布2025年一季报，公司营业收入为5.77亿元，同比下降40.3%；归母净利润亏损4927万元，同比下降171.1%；扣非归母净利润亏损5347万元，同比下降182.7%；经营现金流净额为8104万元，同比下降44.5%；EPS为-0.1095元。截至一季度末，公司总资产56.11亿元，较上年度末下降2.2%；归母净资产为35.28亿元，较上年度末下降1.4%。本期研发投入占营业收入的比例为17.19%，较上年同期增加了7.16个百分点，显示出公司在创新方面的持续努力。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688658":"悦康药业","BK0239":"医药制造"},"translate_title":"Yuekang Pharmaceutical lost 49.27 million yuan in the first quarter, a year-on-year decrease of 171.1%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688658":1},"content_text":"4月28日，悦康药业(688658)公布2025年一季报，公司营业收入为5.77亿元，同比下降40.3%；归母净利润亏损4927万元，同比下降171.1%；扣非归母净利润亏损5347万元，同比下降182.7%；经营现金流净额为8104万元，同比下降44.5%；EPS(全面摊薄)为-0.1095元。截至一季度末，公司总资产56.11亿元，较上年度末下降2.2%；归母净资产为35.28亿元，较上年度末下降1.4%。公司在2025年第一季度报告中提到，其主营业务包括药品研发、生产和销售。公司致力于推动研发投入，特别是在小核酸药物和多肽药物等重点项目上。本期研发投入占营业收入的比例为17.19%，较上年同期增加了7.16个百分点，显示出公司在创新方面的持续努力。在经营策略方面，公司对“银杏叶提取物注射液”进行了价格下调，并相应调整了销售策略。这一调整导致了本报告期内该产品的销售收入和利润贡献减少。尽管面临短期的收入与利润回调，公司依然计划通过优化销售策略和维护核心销售渠道的稳定来应对市场挑战。整体来看，公司的经营活动现金流量净额为8104万元，显示出一定的现金流入能力。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530605405","isCrawlerRequest":true}

悦康药业一季度亏损4927万元 同比降171.1%

精彩评论

悦康药业一季度亏损4927万元同比降171.1%